Lv1
40 积分 2026-08-04 加入
Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase
1小时前
已采纳
A39-10 Assessment of Pharmacokinetic Interactions between Admilparant (BMS-986278) and Nintedanib or Pirfenidone
2小时前
已采纳
A110-10 Efficacy, Safety, and Tolerability of Fipaxalparant in Patients With Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2B Study
2小时前
已采纳
Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11C-BMT-136088 for Lung Imaging in Rhesus Monkeys
2小时前
已采纳
皖公网安备34019202002308
